UNSPSC 51262102: Silodosin

This classification denotes an alpha-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CUZ39LUY82. European Medicines Agency schedules Silodosin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB23152. Silodosin generally arises in the molecular formula C25H32F3N3O4. The term SILODOSIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16., no. 1.2002, list 47.) Most nations schedule silodosin under HS 29339990 and SITC 51577.

As of Q4 2014, SILODOSIN remains the US FDA Preferred Term for this commodity. Silodosin bears US NLM identifiers UMLS ID C1870115 and NCI Concept Code C81372. SMILES: FC(F)(F)COC1C(OCCNC(CC2CC3C(N(CC3)CCCO)C(C2)C(=O)N)C)CCCC1.

UNSPSC 51262102 Silodosin is a Commodity code designated for pharmaceutical products, though the recent state and local opportunities tagged under this code do not reflect silodosin procurement. Instead, Seminole County, Florida has posted an IFB for naloxone and safe drug deactivation systems, indicating a significant mismatch between the code's nominal pharmaceutical scope and the work actually being solicited. The solicitation seeks annual supplies of naloxone units and drug deactivation systems to support community health initiatives, with quarterly deliveries required to the county's community health building. Vendors must meet standard compliance requirements including drug-free workplace certification, E-Verify enrollment, and appropriate insurance coverages; the contract carries a three-month probationary termination clause and is structured as a fixed-fee award with an initial two-year term and one-year renewal option.

Seminole County in Florida represents the sole recent activity identified under this code. The IFB (IFB60459723LAS) was posted on June 30, 2026, with a response deadline of July 26, 2023—a date discrepancy in the source that creates ambiguity about current procurement status. The procurement calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with all shipping and delivery costs to be included in vendor proposals. Bidders must submit electronically through the county's e-procurement portal and provide unit costs for each line item. The contract may be partially funded through FEMA, which introduces additional federal compliance obligations. The code shows minimal recent state and local activity; practitioners should verify whether silodosin procurement under this code occurs through other channels or cooperative purchasing arrangements not surfaced in current public solicitations.